Karus Therapeutics Limited

Karus Therapeutics is a clinical-stage biopharmaceutical company, based in Oxfordshire, UK. We are developing precision medicines to treat cancer patients with a clear unmet medical need and limited treatment options. We currently have two clinical candidates in Phase I studies: KA2507 and KA2237. Our orally-active, small molecule drugs combine targeted and immunotherapeutic mechanisms of action.